Healthcare Roundup – EyeGate Pharma files for 500K-share stock offering, Drugmakers to hike U.S. prices Life Science
Healthcare Roundup – XBiotech says bermekimab sale to J&J closes, Acceleron Pharma teams up with Fulcrum Therapeutics Life Science
Healthcare – Sanofi begins tender offer for Synthorx buy-out, Regeneron’s Ebola treatment gets orphan status Life Science
TRACON Pharmaceuticals, 3D Medicines and Jiangsu Alphamab Announce Partnership for Development of Subcutaneous PD-L1 Single-Domain Antibody in Soft Tissue Sarcoma Life Science
Metabomed Completes a $12.5 Million Raise in Order to Advance Its Lead Program Into Clinical Studies Life Science
Healthcare Roundup – Amgen files U.S. application for Rituxan biosimilar, Gilead files U.S. application for filgotinib Life Science
Healthcare Roundup – White House releases plan, Illumina to pay up to $34M to extend offer for Pacific Bio Life Science
Shandong Fontacea Announces License Agreement with Janssen to Develop and Commercialize Anti-IL17A Monoclonal Antibody Life Science
Healthcare Roundup – Merck adds to aquaculture portfolio, CytoDyn out-licenses U.S. rights to leronlimab for HIV Life Science
Cellestia Biotech AG successfully closes Series B financing round, raising a total of CHF 20 million Life Science
TransThera Biosciences Announces IND Approval from FDA for Clinical Studies of TT-00920 to Treat Chronic Heart Failure Life Science
Healthcare Roundup – U.S. approves Roche-Spark merger, Ad Com Tuesday for AstraZeneca’s Lynparza for maintenance of pancreatic cancer Life Science
